Literature DB >> 9441946

The physiological function of drug-transporting P-glycoproteins.

A H Schinkel1.   

Abstract

The mammalian drug-transporting or mdr1-type P-glycoproteins can extrude a range of structurally diverse, toxic xenobiotic compounds from cells. Our analysis of knockout mice lacking one or both of the mdr1-type P-glycoproteins indicates that a major function of these proteins is the protection of organisms against many of the toxic xenobiotics to which they can potentially be exposed in nature. P-glycoprotein confers protection by limiting the uptake of compounds from the gastrointestinal tract, and by stimulating excretion of compounds in the liver, kidney, and intestine. Moreover, P-glycoprotein in the blood-brain barrier and other blood-tissue barriers protects sensitive organs from exposure to toxic compounds that may have entered the bloodstream. Although we cannot exclude additional physiological functions for mdr1-type P-glycoproteins, these are not vital, since the mdr1-deficient mice are viable and fertile, and do not display obvious phenotypic abnormalities other than hypersensitivity to drugs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441946     DOI: 10.1006/scbi.1997.0068

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  80 in total

Review 1.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis study.

Authors:  T H Tsai; S C Liu; P L Tsai; L K Ho; A Y C Shum; C F Chen
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Effect of hemorrhagic shock on apoptosis and energy-dependent efflux system in the brain.

Authors:  Zhao-Ying Yu; Shinsuke Ono; Maria Spatz; Richard M McCarron
Journal:  Neurochem Res       Date:  2002-12       Impact factor: 3.996

4.  ABCB1 polymorphism and susceptibility to acute lymphoblastic leukemia: a meta analysis.

Authors:  Haiyan Zhang; Zhen Zhang; Guang Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  The pharmacology of novel oral anticoagulants.

Authors:  Tracy A DeWald; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 6.  The mechanism of action of multidrug-resistance-linked P-glycoprotein.

Authors:  Z E Sauna; M M Smith; M Müller; K M Kerr; S V Ambudkar
Journal:  J Bioenerg Biomembr       Date:  2001-12       Impact factor: 2.945

Review 7.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

8.  Keratinocyte growth factor-2 stimulates P-glycoprotein expression and function in intestinal epithelial cells.

Authors:  Seema Saksena; Shubha Priyamvada; Anoop Kumar; Maria Akhtar; Vikas Soni; Arivarasu Natarajan Anbazhagan; Anas Alakkam; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-17       Impact factor: 4.052

9.  Evolutionary conservation of vertebrate blood-brain barrier chemoprotective mechanisms in Drosophila.

Authors:  Fahima Mayer; Nasima Mayer; Leslie Chinn; Robert L Pinsonneault; Deanna Kroetz; Roland J Bainton
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

10.  Citrobacter rodentium Infection Inhibits Colonic P-glycoprotein Expression.

Authors:  Mitul Patel; Anoop Kumar; Dulari Jayawardena; Shubha Priyamvada; Arivarasu N Anbazhagan; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja; Seema Saksena
Journal:  Gene Rep       Date:  2019-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.